{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:23:26Z","timestamp":1790857406716,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"41","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,7,30]],"date-time":"2010-07-30T00:00:00Z","timestamp":1280448000000},"content-version":"vor","delay-in-days":332,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1016\/j.vaccine.2009.07.028","type":"journal-article","created":{"date-parts":[[2009,7,31]],"date-time":"2009-07-31T12:48:26Z","timestamp":1249044506000},"page":"5543-5549","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["TLR expression and NK cell activation after human yellow fever vaccination"],"prefix":"10.1016","volume":"27","author":[{"given":"Patr\u00edcia Cristina","family":"da Costa Neves","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise Cristina","family":"de Souza Matos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rugimar","family":"Marcovistz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Galler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.vaccine.2009.07.028_bib1","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1001\/jama.1996.03540140045025","article-title":"Yellow fever: a decade of reemergence","volume":"276","author":"Robertson","year":"1996","journal-title":"Jama"},{"issue":"2","key":"10.1016\/j.vaccine.2009.07.028_bib2","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1590\/S0037-86822003000200012","article-title":"Yellow fever","volume":"36","author":"Vasconcelos","year":"2003","journal-title":"Rev Soc Bras Med Trop"},{"key":"10.1016\/j.vaccine.2009.07.028_bib3","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1084\/jem.65.6.787","article-title":"The use of yellow fever virus modified by in vitro cultivation for human immunization","volume":"65","author":"Theiler","year":"1937","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2009.07.028_bib4","unstructured":"WHO. Assessment of yellow fever epidemic risk- a decision- making tool for preventive imunization campaigns. Weekly epidemiological record 2007; 18(82):153\u2013160."},{"issue":"2","key":"10.1016\/j.vaccine.2009.07.028_bib5","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1084\/jem.20051720","article-title":"Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity","volume":"203","author":"Querec","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2009.07.028_bib6","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/978-0-387-34814-8_3","article-title":"Understanding the role of innate immunity in the mechanism of action of the live attenuated Yellow Fever vaccine 17D","volume":"590","author":"Querec","year":"2007","journal-title":"Adv Exp Med Biol"},{"issue":"9","key":"10.1016\/j.vaccine.2009.07.028_bib7","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1084\/jem.20051352","article-title":"Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes","volume":"202","author":"Barba-Spaeth","year":"2005","journal-title":"J Exp Med"},{"issue":"9","key":"10.1016\/j.vaccine.2009.07.028_bib8","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.vaccine.2007.12.035","article-title":"Innate immunity phenotypic features point toward simultaneous raise of activation and modulation events following 17DD live attenuated yellow fever first-time vaccination","volume":"26","author":"Martins","year":"2008","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2009.07.028_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2567.2005.02256.x","article-title":"Putting the natural killer cell in its place","volume":"117","author":"O\u2019Connor","year":"2006","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2009.07.028_bib10","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1146\/annurev.immunol.23.021704.115526","article-title":"NK cell recognition","volume":"23","author":"Lanier","year":"2005","journal-title":"Annu Rev Immunol"},{"issue":"27","key":"10.1016\/j.vaccine.2009.07.028_bib11","doi-asserted-by":"crossref","first-page":"10116","DOI":"10.1073\/pnas.0403744101","article-title":"CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells","volume":"101","author":"Sivori","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.vaccine.2009.07.028_bib12","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.cellimm.2006.08.004","article-title":"The direct effects of Toll-like receptor ligands on human NK cell cytokine production and cytotoxicity","volume":"241","author":"Lauzon","year":"2006","journal-title":"Cell Immunol"},{"key":"10.1016\/j.vaccine.2009.07.028_bib13","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1146\/annurev.immunol.21.120601.141126","article-title":"Toll-like receptors","volume":"21","author":"Takeda","year":"2003","journal-title":"Annu Rev Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2009.07.028_bib14","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1038\/ni1138","article-title":"Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming","volume":"5","author":"Martin-Fontecha","year":"2004","journal-title":"Nat Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2009.07.028_bib15","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1590\/S0074-02762005000300021","article-title":"Lymphocyte subset analyses in healthy adults vaccinated with yellow fever 17DD virus","volume":"100","author":"Santos","year":"2005","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"2","key":"10.1016\/j.vaccine.2009.07.028_bib16","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/sj.cdd.4402170","article-title":"NK cells at the interface between innate and adaptive immunity","volume":"15","author":"Moretta","year":"2008","journal-title":"Cell Death Differ"},{"issue":"9","key":"10.1016\/j.vaccine.2009.07.028_bib17","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1093\/intimm\/dxn073","article-title":"Human NK cells directly recognize Mycobacterium bovis via TLR-2 and acquire the ability to kill monocyte-derived DC","volume":"20","author":"Marcenaro","year":"2008","journal-title":"Int Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.07.028_bib18","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1086\/595833","article-title":"Rickettsiae stimulate dendritic cells through Toll-like receptor 4, leading to enhanced NK cell activation in vivo","volume":"199","author":"Jordan","year":"2009","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2009.07.028_bib19","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.cell.2006.02.019","article-title":"Translating innate immunity into immunological memory: implications for vaccine development","volume":"124","author":"Pulendran","year":"2006","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.vaccine.2009.07.028_bib20","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1056\/NEJM200007133430207","article-title":"The immune system. Second of two parts","volume":"343","author":"Delves","year":"2000","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.vaccine.2009.07.028_bib21","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/7403","article-title":"Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo","volume":"5","author":"Fernandez","year":"1999","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/j.vaccine.2009.07.028_bib22","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.4049\/jimmunol.163.8.4207","article-title":"NK cell triggering by the human costimulatory molecules CD80 and CD86","volume":"163","author":"Wilson","year":"1999","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2009.07.028_bib23","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1002\/(SICI)1521-4141(199912)29:12<4022::AID-IMMU4022>3.0.CO;2-O","article-title":"Recognition of autologous dendritic cells by human NK cells","volume":"29","author":"Carbone","year":"1999","journal-title":"Eur J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2009.07.028_bib24","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1084\/jem.20011149","article-title":"Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells","volume":"195","author":"Ferlazzo","year":"2002","journal-title":"J Exp Med"},{"issue":"12","key":"10.1016\/j.vaccine.2009.07.028_bib25","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/nri956","article-title":"Natural killer cells and dendritic cells: rendezvous in abused tissues","volume":"2","author":"Moretta","year":"2002","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2009.07.028_bib26","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1182\/blood-2005-03-1154","article-title":"Natural-killer cells and dendritic cells: \u201cl\u2019union fait la force\u201d","volume":"106","author":"Walzer","year":"2005","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.vaccine.2009.07.028_bib27","doi-asserted-by":"crossref","first-page":"F9","DOI":"10.1084\/jem.20012040","article-title":"Dendritic and natural killer cells cooperate in the control\/switch of innate immunity","volume":"195","author":"Zitvogel","year":"2002","journal-title":"J Exp Med"},{"issue":"5","key":"10.1016\/j.vaccine.2009.07.028_bib28","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.immuni.2008.02.020","article-title":"Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines","volume":"28","author":"Miller","year":"2008","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.vaccine.2009.07.028_bib29","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/(SICI)1096-9071(199810)56:2<159::AID-JMV10>3.0.CO;2-B","article-title":"Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D: a model of human flavivirus infection","volume":"56","author":"Reinhardt","year":"1998","journal-title":"J Med Virol"},{"issue":"Pt 1","key":"10.1016\/j.vaccine.2009.07.028_bib30","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1099\/vir.0.82272-0","article-title":"Restricted replication and lysosomal trafficking of yellow fever 17D vaccine virus in human dendritic cells","volume":"88","author":"Palmer","year":"2007","journal-title":"J Gen Virol"},{"issue":"13","key":"10.1016\/j.vaccine.2009.07.028_bib31","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1084\/jem.20082292","article-title":"Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses","volume":"205","author":"Gaucher","year":"2008","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.vaccine.2009.07.028_bib32","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/ni.1688","article-title":"Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans","volume":"10","author":"Querec","year":"2009","journal-title":"Nat Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2009.07.028_bib33","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S1369-5274(99)80066-6","article-title":"Initial and innate responses to viral infections--pattern setting in immunity or disease","volume":"2","author":"Biron","year":"1999","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.vaccine.2009.07.028_bib34","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1146\/annurev.immunol.17.1.189","article-title":"Natural killer cells in antiviral defense: function and regulation by innate cytokines","volume":"17","author":"Biron","year":"1999","journal-title":"Annu Rev Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.07.028_bib35","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1006\/bcmd.2002.0506","article-title":"The \u201cex vivo\u201d patterns of CD2\/CD7, CD57\/CD11c, CD38\/CD11b, CD45RA\/CD45RO, and CD11a\/HLA-DR expression identify acute\/early and chronic\/late NK-cell activation states","volume":"28","author":"Lima","year":"2002","journal-title":"Blood Cells Mol Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2009.07.028_bib36","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1365-2249.2006.02996.x","article-title":"NK cells, displaying early activation, cytotoxicity and adhesion molecules, are associated with mild dengue disease","volume":"143","author":"Azeredo","year":"2006","journal-title":"Clin Exp Immunol"},{"issue":"13","key":"10.1016\/j.vaccine.2009.07.028_bib37","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.1182\/blood-2004-05-1860","article-title":"p38 MAPK activation controls the TLR-3-mediated up-regulation of cytotoxicity and cytokine production in human NK cells","volume":"104","author":"Pisegna","year":"2004","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.vaccine.2009.07.028_bib38","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1182\/blood.V94.11.3864","article-title":"CD38 triggers cytotoxic responses in activated human natural killer cells","volume":"94","author":"Sconocchia","year":"1999","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.vaccine.2009.07.028_bib39","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/intimm\/13.4.397","article-title":"Signaling through CD38 induces NK cell activation","volume":"13","author":"Mallone","year":"2001","journal-title":"Int Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2009.07.028_bib40","doi-asserted-by":"crossref","first-page":"6648","DOI":"10.4049\/jimmunol.161.12.6648","article-title":"Dependence of both spontaneous and antibody-dependent, granule exocytosis-mediated NK cell cytotoxicity on extracellular signal-regulated kinases","volume":"161","author":"Trotta","year":"1998","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.07.028_bib41","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1365-2249.2006.03317.x","article-title":"Activation\/modulation of adaptive immunity emerges simultaneously after 17DD yellow fever first-time vaccination: is this the key to prevent severe adverse reactions following immunization?","volume":"148","author":"Martins","year":"2007","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.07.028_bib42","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.trstmh.2006.02.019","article-title":"Hepatocyte lesions and cellular immune response in yellow fever infection","volume":"101","author":"Quaresma","year":"2007","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"1","key":"10.1016\/j.vaccine.2009.07.028_bib43","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.it.2003.10.012","article-title":"NK cell and DC interactions","volume":"25","author":"Cooper","year":"2004","journal-title":"Trends Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09010391?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09010391?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:16:28Z","timestamp":1759400188000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09010391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":43,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S0264410X09010391"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.07.028","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TLR expression and NK cell activation after human yellow fever vaccination","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.07.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}